1. Home
  2. DSL vs CADL Comparison

DSL vs CADL Comparison

Compare DSL & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DoubleLine Income Solutions Fund of Beneficial Interests

DSL

DoubleLine Income Solutions Fund of Beneficial Interests

SELL

Current Price

$9.83

Market Cap

1.2B

Sector

Finance

ML Signal

SELL

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$10.30

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DSL
CADL
Founded
2013
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
DSL
CADL
Price
$9.83
$10.30
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
★ $21.75
AVG Volume (30 Days)
723.3K
★ 1.1M
Earning Date
01-01-0001
11-12-2026
Dividend Yield
★ 13.44%
N/A
EPS Growth
N/A
★ 58.62
EPS
★ N/A
N/A
Revenue
N/A
★ $125,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.82
$4.35
52 Week High
$12.34
$14.00

Technical Indicators

Market Signals
Indicator
DSL
CADL
Relative Strength Index (RSI) 29.03 39.77
Support Level N/A $9.86
Resistance Level $11.04 $10.59
Average True Range (ATR) 0.12 0.65
MACD -0.01 -0.14
Stochastic Oscillator 9.55 16.94

Price Performance

Historical Comparison
DSL
CADL

About DSL DoubleLine Income Solutions Fund of Beneficial Interests

DoubleLine Income Solutions Fund is a closed-end management investment company. Its primary investment objective is to seek high income and its secondary objective is to seek capital appreciation. It invests in debt securities and other income-producing investments anywhere in the world, including emerging markets. The company's investment portfolio comprises foreign corporate bonds, U.S. corporate bonds, bank loans, collateralized loan obligations, non-agency commercial mortgage backed obligations, asset-backed obligations, and municipal bonds among others.

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: